-+ 0.00%
-+ 0.00%
-+ 0.00%
Ascentage Pharma corrects AGM date tied to 2021/2022 RSU awards and post-IPO option grants
Share
Listen to the news
Ascentage Pharma corrects AGM date tied to 2021/2022 RSU awards and post-IPO option grants
  • Ascentage Pharma updated terms tied to its 2021 RSU Scheme, 2022 RSU Scheme, and Post IPO Share Option Scheme grants.
  • The annual general meeting date for the Scheme Mandate Limit was corrected to May 19, 2025 from May 20, 2026.
  • All other details from the June 29, 2026 grant announcement remain unchanged.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascentage Pharma Group International published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260713-12241986), on July 13, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending